These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 9748025)
1. A placebo-controlled crossover study of rizatriptan in the treatment of multiple migraine attacks. Rizatriptan Multiple Attack Study Group. Kramer MS; Matzura-Wolfe D; Polis A; Getson A; Amaraneni PG; Solbach MP; McHugh W; Feighner J; Silberstein S; Reines SA Neurology; 1998 Sep; 51(3):773-81. PubMed ID: 9748025 [TBL] [Abstract][Full Text] [Related]
2. Rizatriptan (MAXALT) for the acute treatment of migraine and migraine recurrence. A placebo-controlled, outpatient study. Rizatriptan 022 Study Group. Teall J; Tuchman M; Cutler N; Gross M; Willoughby E; Smith B; Jiang K; Reines S; Block G Headache; 1998 Apr; 38(4):281-7. PubMed ID: 9595867 [TBL] [Abstract][Full Text] [Related]
3. Preference comparison of rizatriptan ODT 10-mg and sumatriptan 50-mg tablet in migraine. Loder E; Brandes JL; Silberstein S; Skobieranda F; Bohidar N; Wang L; Boyle D; Kolodny A; Guerra F; Santanello N; Johnson-Pratt L; Headache; 2001 Sep; 41(8):745-53. PubMed ID: 11576197 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of rizatriptan versus standard care during long-term treatment for migraine. Rizatriptan Multicenter Study Groups. Block GA; Goldstein J; Polis A; Reines SA; Smith ME Headache; 1998; 38(10):764-71. PubMed ID: 11284464 [TBL] [Abstract][Full Text] [Related]
5. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: a randomized, double-blind, placebo-controlled study. Winner P; Lewis D; Visser WH; Jiang K; Ahrens S; Evans JK; Headache; 2002 Jan; 42(1):49-55. PubMed ID: 12005275 [TBL] [Abstract][Full Text] [Related]
6. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: results from a double-blind, single-attack study and two open-label, multiple-attack studies. Visser WH; Winner P; Strohmaier K; Klipfel M; Peng Y; McCarroll K; Cady R; Lewis D; Nett R; Headache; 2004 Oct; 44(9):891-9. PubMed ID: 15447698 [TBL] [Abstract][Full Text] [Related]
7. Within-patient consistency of response of rizatriptan for treating migraine. Dahlöf CG; Lipton RB; McCarroll KA; Kramer MS; Lines CR; Ferrari MD Neurology; 2000 Nov; 55(10):1511-6. PubMed ID: 11094106 [TBL] [Abstract][Full Text] [Related]
8. Rizatriptan in the treatment of menstrual migraine. Silberstein SD; Massiou H; Le Jeunne C; Johnson-Pratt L; McCarroll KA; Lines CR Obstet Gynecol; 2000 Aug; 96(2):237-42. PubMed ID: 10908770 [TBL] [Abstract][Full Text] [Related]
9. Rizatriptan: an update of its use in the management of migraine. Wellington K; Plosker GL Drugs; 2002; 62(10):1539-74. PubMed ID: 12093318 [TBL] [Abstract][Full Text] [Related]
10. Rizatriptan for treatment of acute migraine in patients taking topiramate for migraine prophylaxis. Seeburger JL; Cady RK; Winner P; MacGregor A; Valade D; Ge Y; Zhang Y; Hustad CM; Strickler N; Schaefer E; Connor KM; Ho TW Headache; 2012 Jan; 52(1):57-67. PubMed ID: 22078129 [TBL] [Abstract][Full Text] [Related]
11. Crossover comparison of rizatriptan 5 mg and 10 mg versus sumatriptan 25 mg and 50 mg in migraine. Rizatriptan Protocol 046 Study Group. Goldstein J; Ryan R; Jiang K; Getson A; Norman B; Block GA; Lines C Headache; 1998; 38(10):737-47. PubMed ID: 11284462 [TBL] [Abstract][Full Text] [Related]
12. Early treatment of migraine with rizatriptan: a placebo-controlled study. Mathew NT; Kailasam J; Meadors L Headache; 2004; 44(7):669-73. PubMed ID: 15209688 [TBL] [Abstract][Full Text] [Related]
13. Rizatriptan: a review of its efficacy in the management of migraine. Dooley M; Faulds D Drugs; 1999 Oct; 58(4):699-723. PubMed ID: 10551439 [TBL] [Abstract][Full Text] [Related]
14. Rizatriptan combined with rofecoxib vs. rizatriptan for the acute treatment of migraine: an open label pilot study. Krymchantowski AV; Barbosa JS Cephalalgia; 2002 May; 22(4):309-12. PubMed ID: 12100094 [TBL] [Abstract][Full Text] [Related]
15. Treatment of migraine with rizatriptan: when to take the medication. Hu XH; Raskin NH; Cowan R; Markson LE; Berger ML; Headache; 2002 Jan; 42(1):16-20. PubMed ID: 12005270 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of coadministration of rizatriptan and acetaminophen vs rizatriptan or acetaminophen alone for acute migraine treatment. Freitag F; Diamond M; Diamond S; Janssen I; Rodgers A; Skobieranda F Headache; 2008 Jun; 48(6):921-30. PubMed ID: 18572432 [TBL] [Abstract][Full Text] [Related]
17. Double-blind, placebo-controlled, dose-finding study of rizatriptan (MK-462) in the acute treatment of migraine. Gijsman H; Kramer MS; Sargent J; Tuchman M; Matzura-Wolfe D; Polis A; Teall J; Block G; Ferrari MD Cephalalgia; 1997 Oct; 17(6):647-51. PubMed ID: 9350384 [TBL] [Abstract][Full Text] [Related]
18. Crossover comparison of efficacy and preference for rizatriptan 10 mg versus ergotamine/caffeine in migraine. Christie S; Göbel H; Mateos V; Allen C; Vrijens F; Shivaprakash M; Eur Neurol; 2003; 49(1):20-9. PubMed ID: 12464714 [TBL] [Abstract][Full Text] [Related]
19. Further evaluation of rizatriptan in menstrual migraine: retrospective analysis of long-term data. Silberstein SD; Massiou H; McCarroll KA; Lines CR Headache; 2002 Oct; 42(9):917-23. PubMed ID: 12390621 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of rizatriptan for the treatment of acute migraine in sumatriptan non-responders. Seeburger JL; Taylor FR; Friedman D; Newman L; Ge Y; Zhang Y; Hustad CM; Lasorda J; Fan X; Hewitt D; Ho T; Connor KM Cephalalgia; 2011 May; 31(7):786-96. PubMed ID: 21078681 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]